Empatica Inc.

Company Snapshot

Founded: 2011
Entity Type: Private
Region: U.S.
Headquarter: Massachusetts, U.S.
Key Geographics: U.S., Italy, Republic of Korea
Corporate Address: 1 Broadway, 14th floor, Cambridge Massachusetts 02142 U.S. Tel. +1-866-739-2049 www.empatica.com

Company Overview

Empatica Inc. is an MIT spin-off specializing in passive, and continuous, monitoring of patients with neurological disorders. The company develops algorithms and software that use physiological and behavioral biomarkers for patients, physicians, and researchers to provide real-time human insight and to improve knowledge of human behavior using wearable sensors. Empatica provides an exhaustive variety of research-grade and clinically validated digital biomarkers globally. FDA-cleared products are used in research studies related to stress, sleep, epilepsy, migraine, depression, and other neurological disorders. By partnering with HHS, USAMRDC, and the NASA-funded TRISH, the company has created its flagship medical wearable, EmbracePlus.

Empatica Inc. In Reports

Digital Biomarkers: Global Markets

BCC Research Market Analyst says global market for digital biomarkers is estimated to grow from $5 billion in 2025 to $18.8 billion by the end of 2030.

Epilepsy Monitoring Devices: Global Market Outlook

BCC Research Market Report aims to provide a comprehensive study of the global market for epilepsy monitoring devices.

Chronic Disease Management: Therapeutics, Device Technologies and Global Markets

BCC Research Market Report for Chronic Disease Management. Global Chronic Disease Management market trends, with CAGRs through 2026.

Company's Business Segments

  • Health Monitoring Platform : This segment includes EmbracePlus Wearable, Care Software Suite, Digital Biomarkers, Cloud API for Clinical Trials.

Applications/End User Industries

  • Clinical Trials
  • Actigraphy
  • Remote Patient Monitoring
  • Academic Research
  • Health Care
  • Medical wearables
  • Smartphone
  • Wearable Computing
  • Life Sciences
  • Parkinson’s & Movement Disorders
  • Parkinson's Monitoring
AI Sentiment